These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17393061)

  • 1. A link between monoamine oxidase-A and apoptosis in serum deprived human SH-SY5Y neuroblastoma cells.
    Fitzgerald JC; Ufer C; Billett EE
    J Neural Transm (Vienna); 2007; 114(6):807-10. PubMed ID: 17393061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells.
    Fitzgerald JC; Ufer C; De Girolamo LA; Kuhn H; Billett EE
    J Neurochem; 2007 Dec; 103(6):2189-99. PubMed ID: 17883400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
    Klegeris A; McGeer PL
    Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection.
    Naoi M; Maruyama W; Akao Y; Yi H; Yamaoka Y
    J Neural Transm Suppl; 2006; (71):67-77. PubMed ID: 17447417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron modulates the activity of monoamine oxidase B in SH-SY5Y cells.
    Lu H; Chen J; Huang H; Zhou M; Zhu Q; Yao SQ; Chai Z; Hu Y
    Biometals; 2017 Aug; 30(4):599-607. PubMed ID: 28685208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells.
    Yi H; Akao Y; Maruyama W; Chen K; Shih J; Naoi M
    J Neurochem; 2006 Jan; 96(2):541-9. PubMed ID: 16336631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.
    Inaba-Hasegawa K; Akao Y; Maruyama W; Naoi M
    J Neural Transm (Vienna); 2012 Apr; 119(4):405-14. PubMed ID: 22065207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase-A knockdown in human neuroblastoma cells reveals protection against mitochondrial toxins.
    Fitzgerald JC; Ugun-Klusek A; Allen G; De Girolamo LA; Hargreaves I; Ufer C; Abramov AY; Billett EE
    FASEB J; 2014 Jan; 28(1):218-29. PubMed ID: 24051032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selegiline reduces cisplatin-induced neuronal death in neuroblastoma cells.
    Müller T; Przuntek H; Rieks M; Mackowiak A
    Neurol Res; 2008 May; 30(4):417-9. PubMed ID: 18237459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease.
    Avramovich-Tirosh Y; Amit T; Bar-Am O; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2007 Jan; 100(2):490-502. PubMed ID: 17144902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intracellular monoamine oxidase-A inhibitory activity and the protective effect of small hairtail-related peptides in nerve cells (SH-SY5Y).
    Zhang A; Yang X; Su K; Xie J; Zhang X
    Biosci Biotechnol Biochem; 2024 Feb; 88(3):322-332. PubMed ID: 38066695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells.
    Sanz E; Quintana A; Battaglia V; Toninello A; Hidalgo J; Ambrosio S; Valoti M; Marco JL; Tipton KF; Unzeta M
    J Neurochem; 2008 Jun; 105(6):2404-17. PubMed ID: 18331475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
    Magyar K; Szende B
    Neurotoxicology; 2004 Jan; 25(1-2):233-42. PubMed ID: 14697898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.
    Naoi M; Maruyama W; Shamoto-Nagai M
    J Neural Transm (Vienna); 2018 Nov; 125(11):1635-1650. PubMed ID: 29279995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium alters monoamine oxidase-A parameters in human cerebellar and rat glial C6 cell extracts: possible influence by distinct signalling pathways.
    Cao X; Li XM; Mousseau DD
    Life Sci; 2009 Jul; 85(5-6):262-8. PubMed ID: 19539632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose- and time-dependent switch from apoptosis to necrosis in human neuroblastoma cells.
    Igosheva N; Lorz C; O'Conner E; Glover V; Mehmet H
    Neurochem Int; 2005 Aug; 47(3):216-24. PubMed ID: 15876476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway.
    Ou XM; Chen K; Shih JC
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10923-8. PubMed ID: 16829576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damage.
    Ou XM; Stockmeier CA; Meltzer HY; Overholser JC; Jurjus GJ; Dieter L; Chen K; Lu D; Johnson C; Youdim MB; Austin MC; Luo J; Sawa A; May W; Shih JC
    Biol Psychiatry; 2010 May; 67(9):855-63. PubMed ID: 20022592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase-A promotes protective autophagy in human SH-SY5Y neuroblastoma cells through Bcl-2 phosphorylation.
    Ugun-Klusek A; Theodosi TS; Fitzgerald JC; Burté F; Ufer C; Boocock DJ; Yu-Wai-Man P; Bedford L; Billett EE
    Redox Biol; 2019 Jan; 20():167-181. PubMed ID: 30336354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.